![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 31, 23847-23851, August 4, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 31, 2000, and in revised form, May 2, 2000
Palmitoyl-protein thioesterase-1
(PPT1) is a newly described lysosomal enzyme that hydrolyzes long chain
fatty acids from lipid-modified cysteine residues in proteins.
Deficiency in this enzyme results in a severe neurodegenerative storage
disorder, infantile neuronal ceroid lipofuscinosis. Although the
primary structure of PPT1 contains a serine lipase consensus sequence, the enzyme is insensitive to commonly used serine-modifying reagents phenylmethylsulfonyl fluoride (PMSF) and diisopropylfluorophosphate. In
the current paper, we show that the active site serine in PPT1 is
modified by a substrate analog of PMSF, hexadecylsulfonylfluoride (HDSF) in a specific and site-directed manner. The apparent
Ki of the inhibition was 125 µM (in
the presence of 1.5 mM Triton X-100), and the catalytic
rate constant for sulfonylation (k2) was
3.3/min, a value similar to previously described sulfonylation reactions. PPT1 was crystallized after inactivation with HDSF, and the
structure of the inactive form was determined to 2.4 Å resolution. The
hexadecylsulfonyl was found to modify serine 115 and to snake through a
narrow hydrophobic channel that would not accommodate an aromatic
sulfonyl fluoride. Therefore, the geometry of the active site accounts
for the reactivity of PPT1 with HDSF but not PMSF. These observations
suggest a structural explanation as to why certain serine lipases are
resistant to modification by commonly used serine-modifying reagents.
Palmitoyl-protein thioesterase-1
(PPT1)1 is a newly described
lysosomal hydrolase that removes long chain fatty acids from lipid-modified cysteine residues in fatty acylated proteins (reviewed in Ref. 1). Deficiency of the enzyme leads to a lysosomal storage disease, infantile neuronal ceroid lipofuscinosis, which causes blindness, seizures, and cortical atrophy of the brain (2). Lysosomal
inclusion bodies, termed granular osmiophilic deposits, accumulate in
all tissues, and resemble lipofuscin deposits that occur during normal
aging. In keeping with this important lipid-metabolizing role, PPT1 is
one of the most abundant lysosomal enzymes in the brain (3). In
contrast to most hydrolytic enzymes (such as proteases, lipases,
esterases, and thioesterases), PPT1 is insensitive to the
serine-modifying reagents phenylmethylsulfonyl fluoride (PMSF) and
diisopropylfluorophosphate (DFP) (4). The insensitivity of PPT1 to
these reagents was an important feature of PPT1 because it allowed for
the identification of PPT activity in the presence of contaminating
lipase and protease activities. We wondered whether there might be
structural and/or mechanistic differences between PPT1 and these other
lipolytic enzymes that would account for this observation. We have
recently determined the three-dimensional crystal structure of PPT1 in
the presence and absence of palmitoyl-CoA and shown that palmitate
modifies serine 115 of the enzyme (5), confirming that a serine residue
is the catalytic nucleophile.
In the current study, we show that although PPT1 is insensitive to
inactivation by the serine-reactive reagent PMSF, the enzyme is
covalently modified and inactivated by hexadecylsulfonyl fluoride (HDSF) by an active site-directed mechanism. The modified enzyme was
crystallized, and the bound inhibitor was identified in the structure.
The bound inhibitor defines a narrow, hydrophobic groove leading away
from the active site that would not comfortably accommodate an aromatic
sulfonyl fluoride. These findings suggest that the active site of PPT1
is readily susceptible to sulfonylation and that the insensitivity of
PPT1 to PMSF is due to steric constraints related to the unique
structure of the substrate-binding site.
Materials--
Recombinant bovine PPT1 was overexpressed in the
Sf9 cell baculovirus system and purified from serum-free
SF-900II medium as described previously (6). The purity of the
preparations were >90% as assessed by SDS-polyacrylamide gel
electrophoresis, and the specific activity of the purified enzyme was
0.7-1.2 µmol of palmitoyl-CoA hydrolyzed per min per mg of purified
protein. [3H]Palmitoyl-CoA was synthesized from
[3H]palmitic acid as described previously (7).
Hexadecylsulfonyl fluoride was prepared as described (8).
Palmitoyl-CoA Hydrolase Assays--
The palmitoyl-CoA hydrolase
activity of PPT1 was determined essentially as described (9) by
measuring the release of [3H]palmitic acid from
[3H]palmitoyl-CoA, which was monitored by liquid
scintillation after extraction with Dole's reagent (10). Typically,
30-60 ng of purified recombinant PPT1 was assayed in 100 µl of an
assay buffer containing 50 mM HEPES, pH 7.0, 100 mM NaCl, and 2 mM EDTA for 8 min at
37 °C.
Inactivation of PPT1 by
Hexadecylsulfonylfluoride--
Inactivation of purified recombinant
PPT1 was carried out in buffer containing 50 mM HEPES, pH
7.0, 100 mM NaCl, 2 mM EDTA, and 0.1% Triton
X-100 (buffer A) unless otherwise indicated. Triton X-100 (required to
maintain solubility of the HDSF) was added to reaction mixtures from a
concentrated stock solution (5%). HDSF was added from a concentrated
stock solution (100 mM or lower) in Me2SO.
Incubations were carried out at 37 °C for varying amounts of time,
and the inactivation reactions were stopped by 200-fold or greater
dilution into ice-cold enzyme assay buffer. The inactivation was shown
not to proceed during the assay under these conditions in control
experiments (data not shown).
Kinetics of Inhibition--
The inactivation of PPT1 was assumed
to proceed via formation of an intermediate Michaelis complex as
described previously (11). The reaction is assumed to follow the course
shown in Equation 1.
Crystallization of HDSF-inactivated PPT1--
PPT1 (12 mg/ml in
20 mM HEPES, pH 7.0, 150 mM NaCl, and 0.01%
Triton X-100) was inactivated by the addition of 1 mM HDSF. Crystals grew from sitting drop vapor diffusion experiments containing 3 µl of PPT1/HDSF and 2 µl of reservoir solution equilibrated against a 500-µl reservoir containing 55% polypropylene glycol 400 (Fluka) and 100 mM Bis-Tris, pH 6.5. Crystals were
harvested from the drops in nylon loops and flash-frozen in liquid nitrogen.
X-ray Data Collection and Structure Determination--
Crystals
of HDSF-inactivated PPT1 were analyzed on the A1 beamline at Cornell
High Energy Syncotron Source using an ADSC Quantum-4 CCD Detector (12).
Diffraction data to 2.4 Å were collected, indexed, and integrated with
MOSFLM (13) and scaled and converted to structure factor amplitudes
with SCALA and TRUNCATE from the CCP4 package (14). The
Rsym is 0.064, and the completeness is 96.5%.
Using our previously determined model of uncomplexed PPT1 (5) as a
starting point, density for HDSF was clearly visible in difference
Fourier maps. The inhibitor was built into the density using O (15),
and the complex was refined using simulated annealing, energy
minimization, and individual B-factor refinement with the Crystallography and NMR System Software Suite (16). Topology and
parameter files for HDSF were created using XPLO2D (17). The working
R-factor of the refined model is 0.243, and the
Rfree is 0.288, corresponding to 2210 nonhydrogen protein atoms (the entire mature PPT1 polypeptide from
residues 28-306), 55 sugar atoms (four N-acetylglucosamine residues),
19 atoms from HDSF, and 40 well defined water molecules (corresponding
to peaks greater than 3 In Fig. 1, the chemical structures
of the alkylating agents used in this study, HDSF and PMSF, are shown
for comparison with a natural substrate of PPT1, a palmitoyl cysteine
thioester that normally occurs in the context of a lipid-modified
protein or peptide (18). PPT1 prefers acyl chain lengths of 14-18
carbons (6), and no appreciable hydrolysis is observed for chain
lengths under eight carbons. Previous work has also shown that there
are no major constraints on the nature of the attached "leaving
group," because PPT1 readily hydrolyzes other long chain fatty acyl
thioesters, such as palmitoyl-CoA (6) and S-palmitoyl
thioglucoside (19). The current studies presented below utilized
palmitoyl CoA as a substrate because of the availability of facile
assays using [3H]palmitoyl-CoA. (However, the kinetic
studies presented in Fig. 2 (A
and B) were obtained using either
[3H]palmitoyl-CoA or [3H]palmitate-labeled
Ha-Ras with virtually identical results (data not shown).)
Fig. 2A shows that incubation of PPT1 with PMSF (5 mM) had no appreciable effect on enzyme activity over that
seen with solvent (Me2SO) alone, whereas incubation with
HDSF (5 mM), an alkylating agent with a 16-carbon fatty
acyl chain, resulted in a very rapid loss of enzyme activity, with 80%
inactivation at 1 min and loss of measurable activity at 4 min.
PPT1 has a broad pH optimum with a peak of pH 7.0 when palmitoylated
protein or palmitoyl-CoA is used as the substrate. The rate of
inactivation of PPT1 by HDSF as a function of pH paralleled this broad
pH optimum with the exception that at pH above 7.5, the rate of
inactivation became higher but was confounded by an HDSF-independent
inactivation that was due to enzyme instability (data not shown).
Therefore, the remainder of the studies were conducted at pH 7.0.
As illustrated in Fig. 2B, under pseudo-first-order reaction
conditions (i.e. concentration of HDSF at 20-50 times over
enzyme concentration), the inactivation of PPT1 by HDSF followed
first-order kinetics as shown by the linear relationship between the
natural logarithm of remaining activity and reaction time. No loss of activity was observed within the time period of inactivation when HDSF
was omitted form the reaction mixture (data not shown). To determine
the stoichiometry of inactivation, a precisely determined amount of
enzyme was reacted with increasing amounts of HDSF under conditions
where the reaction was expected to go to completion (2 h at 37 °C),
and the remaining activity was determined (Fig. 2C). 1 mol
of HDSF was needed to inactivate 1 mol of enzyme, suggesting that only
one PPT1 functional group became modified in the course of inactivation.
In our kinetic study we have assumed that the inactivation of the
enzyme by HDSF proceeds through the formation of an intermediate Michaelis complex, as is true for most of the serine hydrolases. To
determine the kinetic constants for inactivation, we measured the rate
of inactivation of PPT1 at increasing HDSF concentrations under
pseudo-first-order conditions. We observed that a plot of the slopes of
the natural logarithm of activity remaining became saturated at
increasing inhibitor concentration, which is a characteristic of
specific (site-directed) irreversible inhibition (20-22). A double
reciprocal plot of the observed first-order rate constant of
inactivation as a function of HDSF concentration is shown in Fig.
2D (open circles). The y intercept
yields the reciprocal of the rate constant k2 of
sulfonylation in the Michaelis complex, and the slope
(Ki/k2) yields the inhibitor
concentration at which the half-maximal rate is observed. From Fig.
2D, we derive a Ki of 125 µM and k2 of 3.3/min for the
inactivation of PPT1 by HDSF. The Ki does not
represent a true Michaelis dissociation constant in this case, because
HDSF is insoluble in aqueous solution and requires Triton X-100 (1.5 mM) for solubilization. In a micellar system, surface
concentration in two dimensions is the relevant value, but because it
is not possible to measure the surface concentration directly, the
concentration is usually expressed as a mole fraction of inhibitor in
the detergent micelle, irrespective of the total concentrations of
inhibitor and detergent (23, 24). In this case, the
Ki reflects a half-maximal rate of inactivation at a
mole fraction of HDSF in the Triton X-100 micelle of 0.061, which is
somewhat higher than the "affinity constant" of 0.022 measured in a
similar experiment that examined the inactivation of Escherichia
coli phospholipase A2 by HDSF (8). The
k2 compares favorably with the inactivation of
chymotrypsin by PMSF (3.1/min) (11) and with the
k2 measured for the inactivation of E. coli phospholipase A2 with HDSF (6-17/min) (8). The
experiments used to generate the curve in Fig. 2D
in the absence of palmitoyl-CoA (open circles) were repeated
in the presence of 15 µM palmitoyl-CoA (closed
circles) and 25 µM palmitoyl-CoA (closed
triangles), which are concentrations that are close to the
Km of PPT1 for palmitoyl CoA (40 µM;
data not shown). As shown in Fig. 2D, substrate protection
from the specific irreversible inhibition of PPT1 by HDSF was
demonstrated, as reflected in the unchanged rate constant of
sulfonylation (k2) in the presence of substrate,
whereas the inhibition constant Ki increased in the
presence of substrate (to 235 and 273 µM at 15 and 25 µm palmitoyl-CoA, respectively). The protection of inactivation by
substrate confirms an active site-directed mechanism.
HDSF-inactivated PPT1 was crystallized and its three-dimensional
crystal structure determined at 2.4 Å resolution (Fig.
3). The binding of HDSF to PPT1 closely
mimics the binding of substrate to PPT1 (5). The hexadecyl chain
occupies the same hydrophobic groove that palmitate was shown to occupy
in our previous structure (Fig.
4A), and serine 115 is
covalently modified by the sulfonyl group. There are no significant
differences observed between the structure of HDSF-inactivated PPT and
the previously determined structures of PPT1 alone and PPT1 bound to
palmitate.
Structural Basis for the Insensitivity of a Serine Enzyme
(Palmitoyl-Protein Thioesterase) to Phenylmethylsulfonyl Fluoride*
,
Department of Internal Medicine and the
Hamon Center for Therapeutic Oncology Research, University of Texas
Southwestern Medical Center, Dallas, Texas 75390-8593, the
§ Department of Chemistry and Chemical Biology, Cornell
University, Ithaca, New York 14853-1301, and the ¶ Department of
Chemistry, Southern Methodist University, Dallas, Texas 75275
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
where E is enzyme, I is inhibitor,
E-I is the intermediate Michaelis complex, and P
is the final inactivated product. When experiments are performed under
pseudo-first-order conditions (i.e. HDSF well in excess over
the enzyme) Equation 1 can be rewritten in the linear form as shown in
Equation 2.
(Eq. 1)
This equation describes the relation between the observed
first-order rate constants for inactivation
(k1), the rate of sulfonylation in the Michaelis
complex (k2), the Michaelis constant
Ki, and the concentration of HDSF. Therefore, a
double reciprocal plot of the observed first-order rate constants
against HDSF concentration yields a straight line with a slope of
Ki/k2 and an intercept of
1/k2 on the y axis. To determine the
first-order rate constants, reactions were initiated by addition of
20-100 µM HDSF into reaction mixtures containing 1 µM of PPT1. Inactivation was followed by determining the
activity remaining at closely spaced time intervals. Activities were
expressed as the percentage of initial activity and plotted on a
semi-log scale as a function of time. From the semi-log plots, the
half-times of inactivation were determined. Observed pseudo-first-order
rate constants were calculated using the following equation.
(Eq. 2)
where t1/2 is the half-time of inactivation
determined from semi-log plot. Once a first-order rate constant for
each HDSF concentration was calculated, a double reciprocal plot of
1/k1 against 1/[I] was obtained.
k2 was calculated from the y
intercept, and Ki was determined from the slope as
described above.
(Eq. 3)
in a sigmaA-weighted
Fo
Fc map with
hydrogen-bonding partners). The average B-factor is 53.8 Å2.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (6K):
[in a new window]
Fig. 1.
Chemical structures of
S-palmitoyl-cysteine (in the context of a fatty
acylated protein), HDSF, and PMSF.

View larger version (12K):
[in a new window]
Fig. 2.
Inhibition of the palmitoyl-CoA hydrolase
activity of PPT1 by HDSF but not PMSF. A, time course
of inactivation of PPT1 (1 µM) in the presence of 5 mM PMSF (
), 5 mM HDSF (
), or dimethyl
sulfoxide (DMSO, solvent,
). B, PPT1 activity
as a function of time of incubation with HDSF under pseudo-first-order
reaction conditions. Bovine recombinant PPT1 (175 nM) was
incubated in the presence of 3 µM HDSF, and aliquots were
removed and assayed for remaining activity at the times indicated. The
inactivation was linear with respect to the natural logarithm of
activity remaining, indicating a bimolecular reaction mechanism.
C, stoichiometry of inactivation of PPT1 by HDSF. Purified
recombinant PPT1 (10 µM) was incubated with increasing
amounts of HDSF for 2 h at 37 °C, and the PPT1 activity
remaining was determined. Inactivation was complete at a molar ratio of
enzyme to inhibitor of 1:1. D, inactivation of PPT1 by HDSF
is inhibited in a competitive manner by increasing concentrations of
palmitoyl-CoA. Double reciprocal plots of the pseudo-first-order rate
constants of inactivation plotted against increasing HDSF
concentrations are shown. Three different palmitoyl CoA concentrations
were plotted: 0 µM palmitoyl-CoA (
), 15 µM palmitoyl-CoA (
), and 25 µM
palmitoyl-CoA (
).

View larger version (65K):
[in a new window]
Fig. 3.
Crystal structure of PPT1 with bound
hexadecylsulfonate. HDSF and the catalytic triad of
Ser115, His289, and Asp233 are
rendered as ball-and-stick models, and the side chains of the residues
lining the substrate-binding pocket are rendered as space-filling
models. This figure and Fig. 4 were created with Molscript (33),
Bobscript (34), and Raster3D (35).

View larger version (68K):
[in a new window]
Fig. 4.
A, HDSF occupies the narrow
substrate-binding cleft in PPT1. B, in contrast, the
Pseudomonas carboxylesterase active site, occupied here by
PMSF, is more open and able to accommodate a wider range of substrates.
C, Pseudomonas carboxylesterase residues and PMSF
(red) superimposed on the PPT1 active site. The structures
were aligned using LSQAB (36) from the CCP4 suite, using the
-carbons of the
sheet and the catalytic triad residues. Note
that the side chain of Met41 occupies the space where PMSF
is bound in the carboxylesterase structure, and the presence of
Ile235 on the other side of the groove does not provide
enough space for PMSF to adopt an alternative conformation.
Superposition of the crystal structure of PMSF-inactivated
Pseudomonas carboxylesterase (Protein Data Bank code 1AUR)
(Fig. 4B) with HDSF-inactivated PPT1 sheds some light on the
molecular details of the specificity of HDSF over PMSF for inactivation of PPT1. The narrow hydrophobic groove leading away from the active site that provides substrate specificity in PPT1 begins with
Met41 and Ile235 and is less than 5 Å wide at
this point (Fig. 4A). The side chain of Met41 in
PPT1 occupies the space where the aromatic ring of PMSF is found in the
carboxylesterase structure (Fig. 4C). The side chain of
Ile235 would block alternative conformations of PMSF from
the active site, and the surrounding environment provides no space to
accommodate alternate conformations of the Met41 side
chain, which would make room for the PMSF. In contrast, HDSF is able to
adopt a conformation that snakes through the channel (Fig.
4A).
| |
DISCUSSION |
|---|
|
|
|---|
Enzymes are often classified mechanistically on the basis of their susceptibility to inactivation by class-specific reagents. This classification scheme has served proteolytic enzymes well; for example, serine proteases are nearly universally sensitive to DFP, and classification on the basis of sensitivity to DFP applies to serine proteases such as the digestive proteases and the blood coagulation factors. Lipolytic enzymes have been more problematic, because sensitivity to class-specific reagents is not universal and because detailed reaction mechanisms for many classes of lipolytic enzymes are not well understood. For example, the enzymes lecithin-cholesterol acyltransferase and lipoprotein lipase are readily inactivated by DFP, but the modification occurs not on the catalytic serine but on a second serine that is probably related instead to the substrate-binding site (25). Several additional secreted lipases, most notably bacterial lipases from Staphylococcus hyicus (26) and E. coli (phospholipase A2) (8) and pancreatic lipase (27, 28), are insensitive to DFP and PMSF and yet use serine as the catalytic nucleophile. In the case of the two bacterial lipases, the involvement of a serine residue in the catalytic mechanism was inferred by their sensitivity to the long chain alkylating agent HDSF (8, 29). Pancreatic lipase has been well documented to utilize a classical serine-based triad mechanism based on analysis of its tertiary structure (30). Therefore, it is clear that certain lipases utilize catalytic serine nucleophiles, but for reasons that have not been clear, their active sites are not susceptible to modification by alkylating agents that are commonly used to modify other lipases, esterases, and proteases.
In the current paper, we have described the modification of the active site serine residue of PPT1, a lysosomal lipolytic enzyme, by HDSF, but not the class-specific reagent, PMSF, and provide important direct structural insights into the basis for the selectivity. We found that there is no inherent lack of reactivity of the active site serine for sulfonylation, as evidenced by the similar kinetic constant for sulfonylation (3.3/min) by HDSF as compared with a classical example, sulfonylation of chymotrypsin by PMSF (3.1/min). However, the crystal structure indicates that PPT1 binds the long chain hydrocarbon in a narrow, hydrophobic groove that would not comfortably accommodate an aromatic sulfonyl fluoride.
Interestingly, the converse conclusion (that a more open configuration
around the active site would lead to facile inactivation by PMSF and
also to a broader substrate specificity) was recently made in relation
to another lipolytic enzyme, the carboxylesterase from
Pseudomonas fluorescens, a member of the
/
hydrolase
superfamily that includes PPT1 (31). As described above, a comparison
of these two enzymes was instructive. The salient structural features of both lipases include an
/
fold structure, which consists of a
central, predominantly parallel
sheet linked by
-helical regions
and a catalytic serine nucleophile located at the tip of a nucleophilic
"elbow." The Pseudomonas carboxylesterase hydrolyzes a
broad spectrum of short chain esters, including phenylacetate, p-nitrophenyl esters of short chain fatty acids, and
triglycerides such as triacetin and tributyrin but does not hydrolyze
substrates with fatty acid chain lengths of over four carbons (32). It is readily inactivated by PMSF, and (as in the case of PPT1 inactivated by HDSF) there are no large structural changes observed upon inhibitor binding. In the structure of the carboxylesterase bound to PMSF, the
active site is found in a relatively open configuration that would
accommodate a broad variety of small molecules close to the active site
but would not (in contrast to PPT1) accept long chain fatty acyl esters
because of interfering loops located at a relatively short distance away.
From these observations and others, it has been suggested that the extent of exposure of the active site may be one of the key elements for determining the substrate specificity of the serine esterases (31). Our observations of HDSF bound to PPT1 would support this view, in that the narrow channel leading from the active site serine in PPT1 places severe constraints on the structures of molecules that could be accommodated there, either as substrates or inhibitors.
In summary, we have shown that a lysosomal thioesterase, PPT1, is
similar to several other "secreted" lipases in showing
insensitivity to class-specific reagents DFP and PMSF. PPT1 is readily
inhibited by a sulfonyl fluoride (HDSF) that is structurally more
similar to its naturally occurring fatty acyl-containing substrates.
The inactivation was shown to be clearly related to modification of a
serine residue, which is in a position to act as the catalytic nucleophile in a classical serine-histidine-aspartic acid triad. The
relatively closed conformation around the active site of PPT1 accounts
for the insensitivity of PPT1 to the classical serine-specific reagent
PMSF and provides a structural explanation for the resistance of serine
lipases to inactivation by serine-modifying class-specific reagents.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant NS35323 and a research grant from the Robert A. Welch Foundation. The crystallographic work was supported by National Institutes of Health Grant CA59021 (to J. C.), a National Institutes of Health Training Grant in Molecular Physics of Biological Systems (to J. J. B.), and the New York State Sea Grant R/SBP-6 (to J. C.). This work is based in part on research conducted at the Cornell High Energy Synchrotron Source, which is supported by the National Science Foundation under Grant DMR-9311772, using the macromolecular diffraction facility, which is supported by National Institutes of Health Grant RR-01646.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and structure factors (code 1EXW) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org).
To whom correspondence should be addressed: Hamon Center for
Therapeutic Oncology Research, Univ. of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-8593. Tel.:
214-648-4911; Fax: 214-648-4940; E-mail:
hofmann@simmons.swmed.edu.
** Current address: Dept. of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138.
Published, JBC Papers in Press, May 4, 2000, DOI 10.1074/jbc.M002758200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PPT1, palmitoyl-protein thioesterase-1; HDSF, hexadecylsulfonyl fluoride; PMSF, phenylmethylsulfonyl fluoride; DFP, diisopropylfluorophosphate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Hofmann, S. L., Lee, L. A., Lu, J. Y., and Verkruyse, L. A. (1997) Neuropediatrics 28, 27-30 |
| 2. | Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., and Peltonen, L. (1995) Nature 376, 584-587 |
| 3. | Sleat, D. E., Sohar, I., Lackland, H., Majercak, J., and Lobel, P. (1996) J. Biol. Chem. 271, 19191-19198 |
| 4. | Camp, L. A., and Hofmann, S. L. (1993) J. Biol. Chem. 268, 22566-22574 |
| 5. | Bellizzi, J. J., Widom, J., Kemp, C., Lu, J.-Y., Das, A. K., Hofmann, S. L., and Clardy, J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4573-4578 |
| 6. | Camp, L. A., Verkruyse, L. A., Afendis, S. J., Slaughter, C. A., and Hofmann, S. L. (1994) J. Biol. Chem. 269, 23212-23219 |
| 7. | Duncan, J. A., and Gilman, A. G. (1996) J. Biol. Chem. 271, 23594-23600 |
| 8. | Horrevoets, A. J. G., Verheij, H. M., and de Hass, G. H. (1991) Eur. J. Biochem. 198, 247-253 |
| 9. | Mentlein, R., Suttorp, M., and Heymann, E. (1984) Arch. Biochem. Biophys. 228, 230-246 |
| 10. | Dole, V. P. (1956) J. Clin. Invest. 35, 150-154 |
| 11. | Gold, A. M., and Fahrney, D. (1964) Biochemistry 3, 783-791 |
| 12. | Szebenyi, D. M. E., Arvai, A., Ealick, S., Laluppa, J. M., and Nielsen, C. (1997) J. Synchrotron Rad. 4, 128-135 |
| 13. | Leslie, A. G. W. (1994) MOSFLM , 5.30 Ed. , MRC Laboratory of Molecular Biology, Cambridge, UK |
| 14. | Collaborative Computational Project Number 4. (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50, 760-763 |
| 15. | Jones, T., and Kjeldgaard, M. (1997) Methods Enzymol. 277, 173-208 |
| 16. | Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921 |
| 17. | Kleywegt, G. J., and Jones, T. A. (1997) Methods Enzymol. 277, 208-230 |
| 18. | Lu, J. Y., Verkruyse, L. A., and Hofmann, S. L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10046-10050 |
| 19. | van Diggelen, O. P., Keulemans, J. L., Winchester, B., Hofman, I. L., Vanhanen, S. L., Santavuori, P., and Voznyi, Y. V. (1999) Mol. Genet. Metab. 66, 240-244 |
| 20. | Malcolm, A. D., and Radda, G. K. (1970) Eur. J. Biochem. 15, 555-561 |
| 21. | Brocklehurst, K. (1979) Biochem. J. 181, 775-778 |
| 22. | Cornish-Bowden, A. (1979) Eur. J. Biochem. 93, 383-385 |
| 23. | Yu, L., and Dennis, E. A. (1992) Bioorg. Med. Chem. Lett. 2, 1343-1348 |
| 24. | Hanel, A. M., Schuttel, S., and Gelb, M. H. (1993) Biochemistry 32, 5949-5958 |
| 25. | Maraganore, J. M., and Heinrikson, R. L. (1986) Trends Biochem. Sci. 11, 497-498 |
| 26. | van Oort, M. G., Deveer, A. M., Dijkman, R., Tjeenk, M. L., Verheij, H. M., de Haas, G. H., Wenzig, E., and Gotz, F. (1989) Biochemistry 28, 9278-9285 |
| 27. | Maylie, M. F., Charles, M., and Desnuelle, P. (1972) Biochim. Biophys. Acta 276, 162-175 |
| 28. | Luthi-Peng, Q., Marki, H. P., and Hadvary, P. (1992) FEBS Lett. 299, 111-115 |
| 29. | Leuveling Tjeenk, M., Bulsink, Y. B. M., Slotboom, A. J., Verheij, H. M., de Hass, G. H., Demleitner, G., and Gotz, F. (1994) Protein Eng. 7, 579-583 |
| 30. | Winkler, F. K., D'Arcy, A., and Hunziker, W. (1990) Nature 343, 771-774 |
| 31. | Kim, K. K., Song, H. K., Shin, D. H., Hwang, K. Y., Choe, S., Yoo, O. J., and Suh, S. W. (1997) Structure 5, 1571-1584 |
| 32. | Hong, K. H., Jang, W. H., Choi, K. D., and Yoo, O. J. (1991) Agric. Biol. Chem. 55, 2839-2845 |
| 33. | Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950 |
| 34. | Esnouf, R. M. (1997) J. Mol. Graph. Model 15, 132-134 |
| 35. | Merritt, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524 |
| 36. | Kabsch, W. (1976) Acta Crystallogr. Sect. A 32, 922-923 |
This article has been cited by other articles:
![]() |
A. Das, M. A. Davis, and L. L. Rudel Identification of putative active site residues of ACAT enzymes J. Lipid Res., August 1, 2008; 49(8): 1770 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Lu and S. L. Hofmann Thematic review series: Lipid Posttranslational Modifications. Lysosomal metabolism of lipid-modified proteins J. Lipid Res., July 1, 2006; 47(7): 1352 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chakravarty, Z. Gu, S. S. Chirala, S. J. Wakil, and F. A. Quiocho Human fatty acid synthase: Structure and substrate selectivity of the thioesterase domain PNAS, November 2, 2004; 101(44): 15567 - 15572. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Calero, P. Gupta, M. C. Nonato, S. Tandel, E. R. Biehl, S. L. Hofmann, and J. Clardy The Crystal Structure of Palmitoyl Protein Thioesterase-2 (PPT2) Reveals the Basis for Divergent Substrate Specificities of the Two Lysosomal Thioesterases, PPT1 and PPT2 J. Biol. Chem., September 26, 2003; 278(39): 37957 - 37964. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xie, D. Yang, L. Liu, B. Xue, and B. Yan Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression Drug Metab. Dispos., May 1, 2002; 30(5): 541 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Huhtinen, J. O'Byrne, P. J. G. Lindquist, J. A. Contreras, and S. E. H. Alexson The Peroxisome Proliferator-induced Cytosolic Type I Acyl-CoA Thioesterase (CTE-I) Is a Serine-Histidine-Aspartic Acid alpha /beta Hydrolase J. Biol. Chem., January 25, 2002; 277(5): 3424 - 3432. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |